tirzepatide phase 2 obesity FDA Approves Tirzepatide, A Potential Blockbuster Drug for Type Diabetes retatrutide triple agonist gip glp-1

Article Review In the adult population, the STEP (Semaglutide Treatment Effect in People with Obesity) trials led to the FDA approval of semaglutide in the use of weight loss in adults with or without diabetes

Why Does Ozempic Cause Diarrhea

The timing of thyroid medication should be maintained consistently, and any gastrointestinal symptoms from weight loss injections that might affect absorption should be promptly reported to your healthcare provider

Pathogenic variants in the WNK4 gene are associated with pseudohypoaldosteronism type IIB

These compounds are not yet FDA-approved and most human evidence is still very limited

Addressing Underlying Health Issues Many individuals struggling with weight issues also face underlying health conditions that can worsen weight gain or hinder weight loss efforts